A review on targeted therapies for lung cancer

A review on targeted therapies for lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Bibliografski detalji
Glavni autor:	Ashraf, Anushey
Daljnji autori:	Khan, Tanisha Tabassum Sayka
Format:	Disertacija
Jezik:	English
Izdano:	Brac University 2023
Teme:	Lung cancer Antibodies Targeted therapy Vaccines Lung cancer > Treatment
Online pristup:	http://hdl.handle.net/10361/19353

Similar Items

Immunotherapy in the Management of Lung Cancer
od: Tasnim, Humayra
Izdano: (2022)

Potential of liposomes for the treatment of lung cancer- a review
od: Mim, Shanzida
Izdano: (2023)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
od: Tania, Umme
Izdano: (2023)

Molecules associated with the development of lung cancer
od: Rahman, Adree, i dr.
Izdano: (2023)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
od: Paul, Pulock
Izdano: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
od: Rahman, Tasnim
Izdano: (2024)

A review on recent advances in drugs for lung cancer treatment
od: Noor, Fouzia
Izdano: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
od: Jeba, Joynob
Izdano: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
od: Razna, Amrin Islam
Izdano: (2019)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Flora, Sanzida Alam
Izdano: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
od: Pial, Sazia Afrin
Izdano: (2018)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
od: Zangmo, Thinley
Izdano: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
od: Hoque, Ismoth Ara
Izdano: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
od: Shabnam, Musharrat
Izdano: (2018)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
od: Bristy, Israt Zerin
Izdano: (2021)

Targeted therapeutic options in the treatment of Breast Cancer
od: Alam, Kazi Tasnuva
Izdano: (2022)

Lung cancer detection and classification using machine learning
od: Arefin, Mahbubul, i dr.
Izdano: (2023)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
od: Das, Reshita
Izdano: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
od: Jahan, Nusrat
Izdano: (2024)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
od: Nandy, Aditi
Izdano: (2022)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
od: Mukti, Roushney Fatima, i dr.
Izdano: (2016)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
od: Kamal, Tasnova
Izdano: (2019)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
od: Nahar, Kamrun
Izdano: (2023)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
od: Ratu, Tabassum
Izdano: (2024)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
od: Parvez, Safi
Izdano: (2023)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
od: Meem, Manila
Izdano: (2023)

A comprehensive review on drug repurposing in cancer treatment
od: Sarkar, Onusree
Izdano: (2024)

The impact of cell penetrating peptides in prospective cancer therapy: a review
od: Nashrah, Zannatul
Izdano: (2023)

Breast cancer therapy through Liposomal drug delivery system
od: Ome, Nusrat Jahan
Izdano: (2024)

Trend in approval of targeted biologics in the last two decades
od: Siddika, Khadiza
Izdano: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
od: Hasan, Amit
Izdano: (2024)

Current practice and approaches of immunotherapy in Cancer treatment
od: Khondokar, Faiza
Izdano: (2022)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Karim, Samia Binte
Izdano: (2024)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
od: Alam, Tahera
Izdano: (2024)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
od: Abir, Shifaty Nur
Izdano: (2024)

A review paper on Nanotechnology based strategies in the treatment of cancer
od: Rahman, Samia
Izdano: (2022)

A review on potential of PARP inhibitors in the treatment of prostate cancer
od: Islam, Saidul
Izdano: (2022)

The uses of bacteria in cancer therapy
od: Saha, Shimul, i dr.
Izdano: (2021)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
od: Chakraborty, Anuradha
Izdano: (2024)

Concepts and challenges of biosimilars to mitigate the oncology drug expenses
od: Tania, Umme
Izdano: (2021)